About us
Who we are
Our strategy
How we are funded
Our people
Governance and structure
Reports and statements
Our impact
Suppliers
Our strategy
Our strategy
Neurodegeneration
Respiratory health
Working with us
Support for MRC researchers
Helping charities
Our partners
Available technologies
Advise & Connect: Covid-19
Funding
LifeArc Ventures
Rare disease research funding
Development Gap Fund
Current funding opportunities
Capabilities
Drug discovery
Antibody humanisation
IP management and technology transfer
Diagnostics development
Careers
Working at LifeArc
Our culture
Benefits and rewards
Students and fellows
How to apply
Job vacancies
News
Latest news
Case studies
Reports and publications
Newsletter
Our strategy
How we're making life science life changing
Home
Our strategy
We're investing £1.3bn by 2030 to solve complex healthcare challenges.
Our strategy
Read about our £1.3bn programme to accelerate scientific innovation and solve some of the most complex healthcare challenges.
Neurodegeneration
We’re investing up to £100m to tackle neurodegenerative conditions.
Respiratory health
Find out how we’re accelerating scientific innovation for people living with bronchiectasis and cystic fibrosis and protecting people from COVID-19.
Contact
Get in touch with LifeArc